Effect of liver toxicity on clinical outcome of patients with nonsmallcell lung cancer treated with pemetrexed

By  

Molecular and Clinical Oncology, Vol. 3, Iss. 2, 2015-01 ,pp. : 334-340

Science Publishers

Access to resources Recommend Favorite

A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer

By Cristofanilli Massimo  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 471-482

Springer Publishing Company

Access to resources Recommend Favorite

Genomic risk prediction of aromatase inhibitor‐related arthralgia in patients with breast cancer using a novel machine‐learning algorithm

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 240-253

John Wiley & Sons Inc

Access to resources Recommend Favorite

Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel

By Poikonen Paula   Sjöström Johanna   Klaar Sigrid   Nittby Lena Tennvall   Sigurdsson Helgi   Madsen Ebbe Lindegaard   Joensuu Heikki   Blomqvist Carl  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 190-195

Informa Healthcare

Access to resources Recommend Favorite

Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial

By Gluz Oleg  

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 643-651

Springer Publishing Company

Access to resources Recommend Favorite